{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:17:29Z","timestamp":1784931449584,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cytogfr.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:42:09Z","timestamp":1651650129000},"page":"39-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["MDSCs might be \u201cAchilles heel\u201d for eradicating CSCs"],"prefix":"10.1016","volume":"65","author":[{"given":"Tao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","article-title":"Immunometabolic interplay in the tumor microenvironment","volume":"39","author":"Kaymak","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cytogfr.2022.04.006_bib3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fimmu.2020.01280","article-title":"Cancer stem cells-origins and biomarkers: perspectives for targeted personalized therapies","volume":"11","author":"Walcher","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.04.006_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00262-014-1527-x","article-title":"Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer","volume":"63","author":"Panni","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2013.08.025","article-title":"Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2","volume":"39","author":"Cui","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","article-title":"Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates","volume":"68","author":"Cassetta","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2021.06.012","article-title":"Intra-arterial infusion chemotherapy utilizing cisplatin inhibits bladder cancer by decreasing the \ufb01brocytic myeloid-derived suppressor cells in an m6A-dependent manner","volume":"137","author":"Mu","year":"2021","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2022.04.006_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/2326-6066.CIR-19-0556","article-title":"Quantification of early-stage myeloid-derived suppressor cells in cancer requires excluding basophils","volume":"8","author":"Khan","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41423-020-00556-w","article-title":"Implications of metabolism-driven myeloid dysfunctions in cancer therapy","volume":"18","author":"Strauss","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib11","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells \u2013 an overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41388-018-0449-z","article-title":"STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells","volume":"38","author":"Guha","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib13","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI60083","article-title":"STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients","volume":"123","author":"Vasquez-Dunddel","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40425-018-0491-y","article-title":"Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation","volume":"7","author":"Lee","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15283\/ijsc18094","article-title":"Predictive role of circulating immune cell subtypes early after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia","volume":"12","author":"Kim","year":"2018","journal-title":"Int. J. Stem Cells"},{"issue":"19","key":"10.1016\/j.cytogfr.2022.04.006_bib16","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/0008-5472.CAN-16-0839","article-title":"Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells","volume":"76","author":"Sarhan","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-030-35723-8_8","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment","volume":"1224","author":"Dysthe","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108597","article-title":"Cancer stemness meets immunity: from mechanism to therapy","volume":"34","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2020.08.020","article-title":"Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer","volume":"139","author":"Salvador-Coloma","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1158\/0008-5472.CAN-18-1106","article-title":"Treatment-induced tumor cell apoptosis and secondary necrosis drive tumor progression in the residual tumor microenvironment through MerTK and IDO1","volume":"79","author":"Werfel","year":"2019","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.cytogfr.2022.04.006_bib21","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1158\/1078-0432.CCR-21-0343","article-title":"Characteristics and spatially defined immune (micro)landscapes of early-stage PD-L1-positive triple-negative breast cancer","volume":"27","author":"Carter","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.04.006_bib22","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.ccell.2021.09.003","article-title":"Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms","volume":"39","author":"Hu","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.32099","article-title":"CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase","volume":"75","author":"Lin","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3892\/ol.2021.12843","article-title":"Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells","volume":"22","author":"Anger-G\u00f3ra","year":"2021","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.cytogfr.2022.04.006_bib25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/carcin\/bgab042","article-title":"On the potential origin and characteristics of cancer stem cells","volume":"42","author":"Trosko","year":"2021","journal-title":"Carcinogenesis"},{"issue":"W1","key":"10.1016\/j.cytogfr.2022.04.006_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"51","key":"10.1016\/j.cytogfr.2022.04.006_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1541-7786.MCR-16-0337","article-title":"Potent EMT and CSC phenotypes are induced by oncostatin-M in pancreatic cancer","volume":"15","author":"Smigiel","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.04.006_bib30","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/1759-7714.13937","article-title":"Zinc-finger E-box-binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib","volume":"12","author":"Nurwidya","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee","year":"2017","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/stem.2320","article-title":"IGF\/STAT3\/NANOG\/Slug signaling axis simultaneously controls epithelial-mesenchymal transition and stemness maintenance in colorectal cancer","volume":"34","author":"Yao","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123837","article-title":"Carbon irradiation overcomes glioma radioresistance by eradicating stem cells and forming an antiangiogenic and immunopermissive niche","volume":"4","author":"Chiblak","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.cytogfr.2022.04.006_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2020.01191","article-title":"Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to reduce immune suppression","volume":"11","author":"Alban","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.04.006_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/NEN.0000000000000183","article-title":"Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue","volume":"74","author":"Gielen","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"23","key":"10.1016\/j.cytogfr.2022.04.006_bib36","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","article-title":"ALDH1A1 activity in tumor-initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.cytogfr.2022.04.006_bib37","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1111\/febs.15311","article-title":"Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2\/p-STAT3 signalling pathway","volume":"287","author":"Li","year":"2020","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.04.006_bib38","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1158\/0008-5472.CAN-15-2528","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL6\/STAT3 and NO\/NOTCH cross-talk signaling","volume":"76","author":"Peng","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2022.04.006_bib39","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.7150\/thno.45280","article-title":"IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer","volume":"11","author":"Gao","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib40","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41388-020-01605-4","article-title":"Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2022.04.006_bib41","first-page":"72","article-title":"Hypoxia and TGF-\u03b21 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors","volume":"5","author":"Wang","year":"2015","journal-title":"Cell\u00a0Biosci."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.20892\/j.issn.2095-3941.2020.0290","article-title":"NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma","volume":"18","author":"Yue","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"18","key":"10.1016\/j.cytogfr.2022.04.006_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201901278","article-title":"Granulocytic myeloid-derived suppressor cells promote the stemness of colorectal cancer cells through exosomal S100A9","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccell.2019.06.009","article-title":"The polycomb repressor complex 1 drives double-negative prostate cancer metastasis by coordinating stemness and immune suppression","volume":"36","author":"Su","year":"2019","journal-title":"Cancer Cell"},{"issue":"91","key":"10.1016\/j.cytogfr.2022.04.006_bib45","doi-asserted-by":"crossref","first-page":"36317","DOI":"10.18632\/oncotarget.26347","article-title":"Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer","volume":"9","author":"Kuroda","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.cytogfr.2022.04.006_bib46","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00262-020-02628-2","article-title":"The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer","volume":"69","author":"Komura","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-021-01460-1","article-title":"IRAK1-regulated IFN-\u03b3 signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies","volume":"20","author":"Cai","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2021.11.008","article-title":"MDSCs sneak CSCs out of (immuno)surveillance","volume":"43","author":"Jim\u00e9nez-Cortegana","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","article-title":"Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma","volume":"518","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib50","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","article-title":"Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion","volume":"59","author":"H\u00f6chst","year":"2013","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.cytogfr.2022.04.006_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001162","article-title":"Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor","volume":"9","author":"Toh","year":"2011","journal-title":"PLOS Biol."},{"issue":"21","key":"10.1016\/j.cytogfr.2022.04.006_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94296","article-title":"Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer","volume":"2","author":"Dominguez","year":"2017","journal-title":"JCI insight"},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00262-017-1997-8","article-title":"Tumor-associated myeloid cells as guiding forces of cancer cell stemness","volume":"66","author":"Sica","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"13","key":"10.1016\/j.cytogfr.2022.04.006_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137068","article-title":"Nitric oxide modulates metabolic processes in the tumor immune microenvironment","volume":"22","author":"McGinity","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Sem. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.04.006_bib56","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/leu.2017.21","article-title":"Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858","volume":"31","author":"Eksioglu","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21873\/anticanres.14817","article-title":"Epithelial-to-mesenchymal transition heterogeneity of circulating tumor cells and their correlation with MDSCs and Tregs in HER2-negative metastatic breast cancer patients","volume":"41","author":"Papadaki","year":"2021","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcmgh.2017.03.003","article-title":"Initiation and maintenance of gastric cancer: a focus on CD44 variant isoforms and cancer stem cells","volume":"4","author":"Zavros","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081916","article-title":"PMN-MDSCs enhance CTC metastatic properties through reciprocal interactions via ROS\/notch\/nodal signaling","volume":"20","author":"Sprouse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cytogfr.2022.04.006_bib60","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1136\/gutjnl-2016-313264","article-title":"SENP1 promotes hypoxia-induced cancer stemness by HIF-1\u03b1 deSUMOylation and SENP1\/HIF-1\u03b1 positive feedback loop","volume":"66","author":"Cui","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib62","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41416-019-0572-9","article-title":"Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion","volume":"121","author":"Chang","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cytogfr.2022.04.006_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120057","article-title":"The impact of hypoxia on immune state in cancer","volume":"286","author":"Mortezaee","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3375","article-title":"Tumor collection\/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity","volume":"8","author":"Kumar","year":"2022","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.04.006_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101574","article-title":"The many facets of tumor heterogeneity: is metabolism lagging behind?","volume":"11","author":"Loponte","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/0008-5472.CAN-13-2584","article-title":"SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1\u03b1-dependent glycolysis","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cytogfr.2022.04.006_bib67","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cytogfr.2022.04.006_bib68","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/carcin\/bgy088","article-title":"Metabolic influence on the differentiation of suppressive myeloid cells in cancer","volume":"39","author":"Porta","year":"2018","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.cytogfr.2022.04.006_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.192","article-title":"Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis","volume":"8","author":"Jian","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fonc.2018.00081","article-title":"Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses","volume":"8","author":"Morrot","year":"2018","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib71","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","article-title":"Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors","volume":"28","author":"Jones","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"16","key":"10.1016\/j.cytogfr.2022.04.006_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165845","article-title":"Lipid metabolism and cancer immunotherapy: immunosuppressive myeloid cells at the crossroad","volume":"21","author":"Bleve","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.04.006_bib73","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41419-021-04217-2","article-title":"Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells","volume":"12","author":"Peng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104286","article-title":"Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy","volume":"362","author":"Adeshakin","year":"2021","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-019-1011-5","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation","volume":"18","author":"Ai","year":"2019","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.cytogfr.2022.04.006_bib76","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1158\/0008-5472.CAN-18-2659","article-title":"MicroRNA-92 expression in CD133(+) melanoma stem cells regulates immunosuppression in the tumor microenvironment via integrin-dependent activation of TGF\u03b2","volume":"79","author":"Shidal","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib77","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.csbj.2021.08.046","article-title":"MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer","volume":"19","author":"Lin","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.04.006_bib78","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/2326-6066.CIR-18-0443","article-title":"The pseudogene Olfr29-ps1 promotes the suppressive function and differentiation of monocytic MDSCs","volume":"7","author":"Shang","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"24","key":"10.1016\/j.cytogfr.2022.04.006_bib79","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41388-020-1322-4","article-title":"Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer","volume":"39","author":"Jiang","year":"2020","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.cytogfr.2022.04.006_bib80","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41388-018-0261-9","article-title":"Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a\/Rora and miR-21\/Pten pathways","volume":"37","author":"Guo","year":"2018","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib81","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41583-018-0026-z","article-title":"Generation of circadian rhythms in the suprachiasmatic nucleus","volume":"19","author":"Hastings","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-396971-2.00009-9","article-title":"The circadian clock in cancer development and therapy","volume":"119","author":"Fu","year":"2013","journal-title":"Prog. Mol. Biol. Transl.Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2013.11.009","article-title":"Circadian properties of cancer stem cells in glioma cell cultures and tumorspheres","volume":"345","author":"Sharma","year":"2014","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cytogfr.2022.04.006_bib84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10585-020-10051-1","article-title":"Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks","volume":"37","author":"De","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.cytogfr.2022.04.006_bib85","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3892\/ijmm.2020.4758","article-title":"Epigallocatechin\u20113\u2013gallate inhibits self\u2011renewal ability of lung cancer stem\u2011like cells through inhibition of CLOCK","volume":"46","author":"Jiang","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib86","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1870811","article-title":"Tumors exploit CXCR4(hi)CD62L(lo) aged neutrophils to facilitate metastatic spread","volume":"10","author":"Peng","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cytogfr.2022.04.006_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.669254","article-title":"CBX4 provides an alternate mode of colon cancer development via potential influences on circadian rhythm and immune infiltration","volume":"9","author":"Wei","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.cytogfr.2022.04.006_bib88","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00011-017-1052-4","article-title":"Expansion of CD11b(+)Ly6G(high) and CD11b(+)CD49d(+) myeloid cells with suppressive potential in mice with chronic inflammation and light-at-night-induced circadian disruption","volume":"66","author":"Perfilyeva","year":"2017","journal-title":"Inflamm. Res."},{"issue":"6516","key":"10.1016\/j.cytogfr.2022.04.006_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cytogfr.2022.04.006_bib90","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tcb.2021.03.011","article-title":"Cancer physical hallmarks as new targets for improved immunotherapy","volume":"31","author":"Guo","year":"2021","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.cytogfr.2022.04.006_bib91","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1158\/0008-5472.CAN-17-0915","article-title":"CCR5 governs DNA damage repair and breast cancer stem cell expansion","volume":"78","author":"Jiao","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib92","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1158\/0008-5472.CAN-19-3360","article-title":"Pharmacologic activation of LXR alters the expression profile of tumor-associated macrophages and the abundance of regulatory T cells in the tumor microenvironment","volume":"81","author":"Carb\u00f3","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib93","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/0008-5472.CAN-19-2830","article-title":"NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer","volume":"80","author":"Nacarelli","year":"2020","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.cytogfr.2022.04.006_bib94","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2217\/nnm-2020-0003","article-title":"Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer","volume":"15","author":"Ss Pindiprolu","year":"2020","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib95","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-18-1232","article-title":"Inhibition of LEF1-mediated DCLK1 by niclosamide attenuates colorectal cancer stemness","volume":"25","author":"Park","year":"2019","journal-title":"Clinical Cancer Res."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.04.006_bib96","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1158\/1535-7163.MCT-19-0004","article-title":"Targeting PI3K\/Akt\/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment","volume":"18","author":"Kahraman","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41420-018-0084-z","article-title":"Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells","volume":"4","author":"Chung","year":"2018","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.cytogfr.2022.04.006_bib98","doi-asserted-by":"crossref","first-page":"G203","DOI":"10.1152\/ajpgi.00193.2016","article-title":"Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases","volume":"311","author":"Liepelt","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/febs.14998","article-title":"Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids","volume":"287","author":"Fern\u00e1ndez-Barral","year":"2020","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jcmgh.2020.05.010","article-title":"Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK\/STAT pathway in intestine","volume":"10","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2022.04.006_bib101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.intimp.2016.07.035","article-title":"Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer","volume":"39","author":"Liu","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.cytogfr.2022.04.006_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.452","article-title":"Curcumin reversed chronic tobacco smoke exposure induced urocystic EMT and acquisition of cancer stem cells properties via Wnt\/\u03b2-catenin","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cytogfr.2022.04.006_bib103","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/CAD.0000000000000584","article-title":"Sonic hedgehog and Wnt\/\u03b2-catenin pathways mediate curcumin inhibition of breast cancer stem cells","volume":"29","author":"Li","year":"2018","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"10.1016\/j.cytogfr.2022.04.006_bib104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5487\/TR.2017.33.4.273","article-title":"Cancer chemopreventive potential of procyanidin","volume":"33","author":"Lee","year":"2017","journal-title":"Toxicol. Res."},{"issue":"18","key":"10.1016\/j.cytogfr.2022.04.006_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184509","article-title":"PD-1\/PD-L1 checkpoints and resveratrol: a controversial new way for a therapeutic strategy","volume":"13","author":"Delmas","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.cytogfr.2022.04.006_bib106","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/08820139.2010.487083","article-title":"Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice","volume":"39","author":"Muralikrishnan","year":"2010","journal-title":"Immunol. Investig."},{"issue":"11","key":"10.1016\/j.cytogfr.2022.04.006_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115990","article-title":"Combined gemcitabine and immune-checkpoint inhibition conquers anti-PD-L1 resistance in low-immunogenic mismatch repair-deficient tumors","volume":"22","author":"Salewski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.cytogfr.2022.04.006_bib108","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/1078-0432.CCR-15-1912","article-title":"Targeting suppressive myeloid cells potentiates checkpoint inhibitors to control spontaneous neuroblastoma","volume":"22","author":"Mao","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2022.04.006_bib109","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1038\/s41598-018-27409-x","article-title":"CSF-1\/CSF-1R axis is associated with epithelial\/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer","volume":"8","author":"Kai","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610122000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610122000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:00:17Z","timestamp":1761217217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610122000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":109,"alternative-id":["S1359610122000284"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2022.04.006","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MDSCs might be \u201cAchilles heel\u201d for eradicating CSCs","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}